PDE5A and chronic kidney disease: Daily treatment with PDE5 inhibitors could attenuate kidney injury and BP elevation in models of diabetic nephropathy, renal ischemia‐reperfusion injury, and CKD (Fang et al., 2013; Li et al., 2012; Rodríguez‐Iturbe et al., 2005; Stegbauer et al., 2013).